KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) EBT Margin (2016 - 2025)

Zimmer Biomet Holdings has reported EBT Margin over the past 17 years, most recently at 4.37% for Q4 2025.

  • Quarterly results put EBT Margin at 4.37% for Q4 2025, down 992.0% from a year ago — trailing twelve months through Dec 2025 was 10.09% (down 341.0% YoY), and the annual figure for FY2025 was 10.09%, down 341.0%.
  • EBT Margin for Q4 2025 was 4.37% at Zimmer Biomet Holdings, down from 13.95% in the prior quarter.
  • Over the last five years, EBT Margin for ZBH hit a ceiling of 15.66% in Q1 2023 and a floor of 4.1% in Q4 2022.
  • Median EBT Margin over the past 5 years was 11.69% (2024), compared with a mean of 10.66%.
  • Peak annual rise in EBT Margin hit 4162bps in 2021, while the deepest fall reached -3412bps in 2021.
  • Zimmer Biomet Holdings' EBT Margin stood at 1.96% in 2021, then plummeted by -309bps to 4.1% in 2022, then soared by 458bps to 14.66% in 2023, then fell by -3bps to 14.28% in 2024, then crashed by -69bps to 4.37% in 2025.
  • The last three reported values for EBT Margin were 4.37% (Q4 2025), 13.95% (Q3 2025), and 10.81% (Q2 2025) per Business Quant data.